Business Description
Swedish Orphan Biovitrum (Sobi) is a Swedish pharmaceutical company founded in 1939 and based in Stockholm, serving patients across Europe, North America, the Middle East, Asia, and Australia. The company focuses on rare and serious diseases, offering a broad range of specialty medicines that treat conditions such as haemophilia, immune disorders, and certain blood cancers. Sobi works alongside partners including Sanofi, Apellis Pharmaceuticals, and ADC Therapeutics to develop and deliver these treatments to patients who have few or no other options.
